These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9250552

  • 1. Fentanyl pharmacokinetics in patients undergoing renal transplantation.
    Koehntop DE, Rodman JH.
    Pharmacotherapy; 1997; 17(4):746-52. PubMed ID: 9250552
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D, Upton R, Christrup L, Popper L.
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.
    Carroll GL, Hooper RN, Boothe DM, Hartsfield SM, Randoll LA.
    Am J Vet Res; 1999 Aug; 60(8):986-91. PubMed ID: 10451210
    [Abstract] [Full Text] [Related]

  • 5. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [Abstract] [Full Text] [Related]

  • 6. The population pharmacokinetics of fentanyl in patients undergoing living-donor liver transplantation.
    Jin SJ, Jung JY, Noh MH, Lee SH, Lee EK, Choi BM, Song MH, Noh GJ.
    Clin Pharmacol Ther; 2011 Sep; 90(3):423-31. PubMed ID: 21814196
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases.
    Seay RE, Larson TA, Toscano JP, Bostrom BC, O'Leary MC, Uden DL.
    Pharmacotherapy; 1995 Sep; 15(1):52-8. PubMed ID: 7739946
    [Abstract] [Full Text] [Related]

  • 8. End-stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil.
    Dahaba AA, Oettl K, von Klobucar F, Reibnegger G, List WF.
    Can J Anaesth; 2002 Apr; 49(4):369-74. PubMed ID: 11927475
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D, Atanasova I, Dimitrova V, Robeva R, Unger S, Mück W.
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of continuous infusion fentanyl in newborns.
    Santeiro ML, Christie J, Stromquist C, Torres BA, Markowsky SJ.
    J Perinatol; 1997 Aug; 17(2):135-9. PubMed ID: 9134513
    [Abstract] [Full Text] [Related]

  • 11. Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation.
    Koehntop DE, Noormohamed SE, Fletcher CV.
    Pharmacotherapy; 1994 Aug; 14(5):592-9. PubMed ID: 7997393
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of alfentanil in chronic renal failure.
    Chauvin M, Lebrault C, Levron JC, Duvaldestin P.
    Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of fentanyl in neonates.
    Koehntop DE, Rodman JH, Brundage DM, Hegland MG, Buckley JJ.
    Anesth Analg; 1986 Mar; 65(3):227-32. PubMed ID: 3954090
    [Abstract] [Full Text] [Related]

  • 15. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
    Masica AL, Girard TD, Wilkinson GR, Thomason JW, Truman Pun B, Nair UB, Light RW, Canonico AE, Dunn J, Pandharipande P, Shintani AK, Ely EW.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of sufentanil in obese patients.
    Schwartz AE, Matteo RS, Ornstein E, Young WL, Myers KJ.
    Anesth Analg; 1991 Dec; 73(6):790-3. PubMed ID: 1835321
    [Abstract] [Full Text] [Related]

  • 17. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N, Ratanajamit C, Kasiwong S, Wangsiripaisan A.
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [Abstract] [Full Text] [Related]

  • 18. Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients.
    Kang SW, Lee SW, Lee IH, Kim BS, Choi KH, Lee HY, Han DS.
    Adv Perit Dial; 1997 Jul; 13():249-52. PubMed ID: 9360692
    [Abstract] [Full Text] [Related]

  • 19. Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants.
    Saarenmaa E, Neuvonen PJ, Fellman V.
    J Pediatr; 2000 Jun; 136(6):767-70. PubMed ID: 10839874
    [Abstract] [Full Text] [Related]

  • 20. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers.
    Yassen A, Olofsen E, Romberg R, Sarton E, Teppema L, Danhof M, Dahan A.
    Clin Pharmacol Ther; 2007 Jan; 81(1):50-8. PubMed ID: 17185999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.